Achilles Therapeutics Addresses Nasdaq Notice
Company Announcements

Achilles Therapeutics Addresses Nasdaq Notice

Achilles Therapeutics Plc (ACHL) has released an update.

Achilles Therapeutics Plc, a biopharmaceutical company, has received a notice from Nasdaq for not meeting the minimum bid price requirement but remains listed on the Nasdaq Global Select Market. The company has 180 days to comply with the $1.00 minimum bid price rule by maintaining its share price above that threshold for at least ten consecutive business days. Despite the notice, Achilles Therapeutics’ operations remain unaffected, and it is exploring options to regain compliance.

For further insights into ACHL stock, check out TipRanks’ Stock Analysis page.


Price Change
S&P 500
Dow Jones
Nasdaq 100

Popular Articles